OnCore icon

OnCore replaces TASCS across the AHC for new studies

Academic Health Center (AHC) researchers will no longer enter new studies into the Time and Study Collection System (TASCS), thanks to the transition to the OnCore clinical trial management system.

After Oct. 1, TASCS -- previously used for studies requiring Fairview/University of Minnesota Physicians billing and budgeting -- will only be used if a study had already been entered into the system, such as to facilitate that study’s post-award process.

AHC researchers now use OnCore for a wide range of activities throughout a clinical trial’s life cycle, including to collect specific data elements required by the AHC. Having an AHC “minimal footprint” outlining which studies users should enter into the clinical trial management system helps improve accuracy and consistency within units and across the University.  

Like TASCS, participant visits must be entered into OnCore within 72 hours for billing compliance.

“Shifting from TASCS to OnCore is a significant milestone for the AHC research community,” says Josh Fehrmann, who manages the clinical trial management system’s implementation. “Because OnCore is a single, comprehensive system that can support most aspects of a clinical trial, it helps streamline our research infrastructure.”

OnCore also contributes to a more streamlined infrastructure by integrating with other enterprise-wide systems. For example, system users can populate Epic, Fairview’s electronic health record (EHR), with some of the data from OnCore, and vice versa.

CTSI is deploying OnCore across the AHC as part of its overarching effort to create an integrated research infrastructure, and enhance the efficiency and quality of health research. CTSI's financial investment covers the system's upfront cost as well as staff and resources to provide transition assistance, training, and ongoing support.

Since August 2013, over 400 people across various departments used OnCore to manage more than 1,100 research studies.